Takeda Pharmaceutical Company Limited

4502.T

$8.05T

Mega Cap

TSEBiotechnology🇺🇸North America47.5K employees

Drugs in Pipeline

178

Phase 3 Programs

127

Upcoming Catalysts

Next Catalyst

Feb 10, 2026

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

6 upcoming, 0 past

⭐Phase 3Next

TAK-881 Phase 3 Results Expected

Feb 10, 2026TAK-88165

Primary completion for TAK-881 trial (NCT05755035) in Primary Immunodeficiency Diseases (PID)

Source

Phase 2

TAK-360 Phase 2 Results Expected

Mar 23, 2026TAK-36040

Primary completion for TAK-360 trial (NCT06952699) in Narcolepsy Type 2

Source

⭐Phase 3

TAK-279 Phase 3 Results Expected

May 7, 2026TAK-2791,950

Primary completion for TAK-279 trial (NCT06550076) in Plaque Psoriasis

Source

Phase 2

TAK-755 Phase 2 Results Expected

Jun 11, 2026TAK-75533

Primary completion for TAK-755 trial (NCT05714969) in Thrombotic Thrombocytopenic Purpura (TTP)

Source

⭐Phase 3

TAK-788 Phase 3 Results Expected

Oct 31, 2026TAK-788354

Primary completion for TAK-788 trial (NCT04129502) in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Source

⭐Phase 3

Maribavir Phase 3 Results Expected

Jan 18, 2027Maribavir80

Primary completion for Maribavir trial (NCT05319353) in Cytomegalovirus (CMV)

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

VONVENDI

Phase 3

Von Willebrand Disease (VWD)

REPLAGAL

Phase 3

Fabry Disease

IGSC 20% infusion

Phase 3

Primary Immunodeficiency Disease

Apremilast

Phase 3

Plaque Psoriasis

Febuxostat

Phase 3

Cardiovascular Disease

TAK-438

Phase 3

Erosive Esophagitis

Alogliptin and glimepiride

Phase 3

Type 2 Diabetes Mellitus

Pioglitazone

Phase 3

Diabetes Mellitus

Vedolizumab 300 mg IV

Phase 3

Colitis, Ulcerative

Vedolizumab SC 108 mg

Phase 3

Crohn's Disease

Vonoprazan

Phase 3

Helicobacter Pylori

Ixazomib

Phase 3

Relapsed Multiple Myeloma

Alogliptin and glyburide

Phase 3

Diabetes Mellitus

Alogliptin

Phase 3

Diabetes Mellitus

Azilsartan medoxomil

Phase 3

Hypertension

SYR-322-MET

Phase 3

Clinical Pharmacology

TAK-438 10 mg

Phase 3

Non-erosive Gastroesophageal Reflux Disease

Lapaquistat acetate

Phase 3

Hypercholesterolemia

Vonicog Alfa

Phase 3

Von Willebrand Disease (VWD)

TAK-279

Phase 3

Generalized Pustular Psoriasis

Relugolix

Phase 3

Uterine Fibroids

Metformin

Phase 3

Diabetes Mellitus

Dexlansoprazole MR

Phase 3

Esophagitis, Reflux

Alogliptin and pioglitazone

Phase 3

Type 2 Diabetes Mellitus

Vortioxetine

Phase 3

Major Depressive Disorder

Maribavir

Phase 3

Cytomegalovirus (CMV)

Vedolizumab

Phase 3

Ulcerative Colitis

TAK-559

Phase 3

Diabetes Mellitus

Teduglutide

Phase 3

Short Bowel Syndrome

Pantoprazole

Phase 3

GERD

Azilsartan medoxomil and chlorthalidone

Phase 3

Safety

Lu AA21004

Phase 3

Major Depressive Disorder

TAK-536TCH tablet

Phase 3

Essential Hypertension

YF-17D

Phase 3

Dengue

Vortioxetine tablets

Phase 3

Major Depressive Disorder

Ixazomib Citrate

Phase 3

Multiple Myeloma

Mezagitamab

Phase 3

Kidney Disease

Lapaquistat acetate and simvastatin

Phase 3

Hypercholesterolemia

Upadacitinib

Phase 3

Crohn's Disease

MOVIPREP

Phase 3

Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

Lapaquistat acetate and atorvastatin

Phase 3

Dyslipidemia

Velaglucerase Alfa

Phase 3

Gaucher Disease

Lapaquistat acetate and rosuvastatin

Phase 3

Hypercholesterolemia

High Dose Colchicine (4.8 mg total dose)

Phase 3

Gout

TAK-755

Phase 3

Thrombotic Thrombocytopenic Purpura (TTP)

TDV

Phase 3

Healthy Volunteers

Fazirsiran Injection

Phase 3

Alpha1-Antitrypsin Deficiency

Elritercept

Phase 3

Myelodysplastic Syndromes

TAK-019

Phase 3

Coronavirus Disease (COVID-19)

NE-58095 IR

Phase 3

Involutional Osteoporosis

Peginesatide

Phase 3

Anemia

TAK-330

Phase 3

Coagulation Disorder

TAK-875

Phase 3

Diabetes Mellitus, Type 2

Idursulfase-IT

Phase 3

Hunter Syndrome

Azacitidine

Phase 3

Myelodysplastic Syndrome

Glipizide

Phase 3

Diabetes Mellitus

Zasocitinib

Phase 3

Nonsegmental Vitiligo

Lansoprazole

Phase 3

Erosive Esophagitis

Esomeprazole

Phase 3

Healthy Volunteers

Glimepiride

Phase 3

Diabetic Patients

Alogliptin and metformin

Phase 3

Type 2 Diabetes Mellitus

Parathyroid Hormone (PTH)

Phase 3

Osteoporosis

TAP-144-SR(6M)

Phase 3

Premenopausal Breast Cancer

Allopurinol

Phase 3

Hyperuricosuria

Venticute

Phase 3

Pneumonia

Azilsartan medoxomil - chlorthalidone

Phase 3

Essential Hypertension

Lubiprostone

Phase 3

Constipation

Chlorthalidone

Phase 3

Hypertension

Adynovate

Phase 3

Hemophilia A

Alogliptin and voglibose

Phase 3

Type 2 Diabetes Mellitus

Bismuth-Containing Quadruple Therapy

Phase 3

Duodenal Ulcer

Azilsartan Medoxomil and amlodipine

Phase 3

Hypertension

Magnesium Pantoprazole

Phase 3

GERD

Vedolizumab SC

Phase 3

Colitis, Ulcerative

Rosiglitazone

Phase 3

Diabetes Mellitus

Bicalutamide

Phase 3

Prostate Cancer

TAK-861

Phase 3

Narcolepsy Type 1

Azilsartan

Phase 3

Pediatric Hypertension

9vHPV Vaccine

Phase 3

Dengue Fever

TVP-1012 1mg

Phase 3

Parkinson's Disease

Zopiclone

Phase 3

Balance

Insulin

Phase 3

Diabetes Mellitus

Ponatinib

Phase 3

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Duloxetine

Phase 3

Generalized Anxiety Disorder

Atorvastatin

Phase 3

Hypercholesterolemia

Olmesartan medoxomil-hydrochlorothiazide

Phase 3

Essential Hypertension

Ramipril

Phase 3

Hypertension

Vedolizumab IV

Phase 3

Crohn's Disease (CD)

Valsartan

Phase 3

Hypertension

Simvastatin

Phase 3

Hypercholesterolemia

Amoxicillin

Phase 3

H. Pylori Infection

Darvadstrocel

Phase 3

Complex Perianal Fistulas in Adult Participants With Crohn's Disease

Febuxostat IR

Phase 3

Gout

TAK-672

Phase 3

Acquired Hemophilia A

Tetravalent Dengue Vaccine (TDV)

Phase 3

Healthy Volunteers

Adalimumab

Phase 3

Colitis, Ulcerative

Gefarnate

Phase 3

Stomach Ulcer

Intranasal Fentanyl Spray (INFS)

Phase 3

Break Through Pain

TVP-1012 0.5mg

Phase 3

Parkinson's Disease

Takeda's Dengue Tetravalent Vaccine (Live, Attenuated) (TDV)

Phase 3

Dengue Fever

Metformin hydrochloride

Phase 3

Type 2 Diabetes Mellitus

omega-3-acid ethyl esters 90 (TAK-085)

Phase 3

Hypertriglyceridemia

TAK-881

Phase 3

Primary Immunodeficiency Diseases (PID)

Pioglitazone and metformin

Phase 3

Diabetes Mellitus

Olmesartan medoxomil and hydrochlorothiazide

Phase 3

Essential Hypertension

Lansoprazole microgranules suspension

Phase 3

Gastroesophageal Reflux Disease

Concomitant Antibiotic Therapy

Phase 3

Pouchitis

TAK-788

Phase 3

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

TAK-743 300 mg

Phase 3

Hereditary Angioedema

Cyclobenzaprine HCl

Phase 3

Neck Pain

TAK-625

Phase 3

Alagille Syndrome (ALGS)

TAK-003

Phase 3

Dengue Fever

TAK-816

Phase 3

Healthy Volunteers

Brigatinib

Phase 3

ALK-positive Advanced NSCLC

Cyproterone acetate

Phase 3

Adenocarcinoma, Prostate

Escitalopram

Phase 3

Treatment Outcome

TAK-816+ DPT-TAKEDA

Phase 3

Immunization

Lapaquistat acetate and lipid-lowering therapy

Phase 3

Type 2 Diabetes

Actovegin

Phase 3

Post-Stroke Cognitive Impairment (PSCI)

Alectinib

Phase 3

ALK+ Advanced NSCLC

HAV Vaccine

Phase 3

Healthy Volunteers

TAK-583

Phase 3

Diabetic Neuropathies

Leuprorelin

Phase 3

Prostatic Neoplasms

Dexlansoprazole

Phase 3

Gastroesophageal Reflux Disease

Resatorvid

Phase 3

Sepsis

SYR-472

Phase 3

Diabetes Mellitus

Ramelteon

Phase 3

Transient Insomnia

Soticlestat

Phase 2

15q Duplication Syndrome

Zasocitinib (Dose A)

Phase 2

Hidradenitis Suppurativa

Norwalk VLP vaccine

Phase 2

Acute Gastroenteritis

TAK-853

Phase 2

Ovarian Cancer

Lenalidomide

Phase 2

Relapsed and/or Refractory Multiple Myeloma

Doxorubicin

Phase 2

Hodgkin Disease

NoV Vaccine

Phase 2

Healthy Volunteers

TDV Liquid Formulation 1

Phase 2

Dengue Fever

Niraparib

Phase 2

Ovarian Cancer

Ramelteon and gabapentin

Phase 2

Sleep Initiation and Maintenance Disorders

TAK-981

Phase 2

Advanced or Metastatic Solid Tumors

Enoxaparin

Phase 2

Venous Thromboembolism

TAK-442

Phase 2

Acute Coronary Syndrome

TAK-783 and methotrexate

Phase 2

Arthritis, Rheumatoid

Ramelteon and doxepin

Phase 2

Sleep Initiation and Maintenance Disorders

Brentuximab Vedotin

Phase 2

Hodgkin Disease

TAK-850 0.5 mL injection

Phase 2

Influenza Infection

Daratumumab

Phase 2

Multiple Myeloma

TIMP-GLIA

Phase 2

Celiac Disease

vortioxetine (Lu AA21004)

Phase 2

Depressive Disorder, Major

Cabozantinib

Phase 2

Advanced Hepatocellular Carcinoma

Panitumumab + TAS-102

Phase 2

Colorectal Cancer

Norovirus GI.1/GII.4 Bivalent VLP Vaccine

Phase 2

Norovirus

TAK-360

Phase 2

Narcolepsy Type 2

Sitagliptin

Phase 2

Diabetes Mellitus, Type 2

Voglibose

Phase 2

Diabetes Mellitus, Type 2

Pevonedistat

Phase 2

Acute Myeloid Leukemia (AML)

Norovirus Bivalent Vaccine

Phase 2

Prevention From Norovirus Infection

TAK-935

Phase 2

Epilepsy

TAK-071

Phase 2

Parkinson Disease

Leuprorelin (GF)

Phase 2

Uterine Fibroids

Subcutaneous injection of TAK-850

Phase 2

Influenza Infection

TAK-128

Phase 2

Diabetic Neuropathies

Olmesartan

Phase 2

Hypertension

TAK-079

Phase 2

Myasthenia Gravis

TAK-954

Phase 2

Diabetic Gastroparesis

oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

Phase 2

Colorectal Carcinoma

NDI-034858

Phase 2

Psoriatic Arthritis

TAK-062

Phase 2

Celiac Disease

Pioglitazone and insulin

Phase 2

Diabetes Mellitus

NoV GI.1/GII.4 Bivalent VLP Vaccine

Phase 2

Healthy Volunteers

Hepatitis A Vaccine

Phase 2

Healthy Volunteers

Ilaprazole

Phase 2

Esophagitis

TAK-007

Phase 2

Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

TAK-385

Phase 2

Endometriosis

Namilumab

Phase 2

Plaque Psoriasis

Lapaquistat acetate and fenofibrate

Phase 2

Hyperlipidemias

TAK-850

Phase 2

Influenza

Norovirus Bivalent VLP Vaccine

Phase 2

Norovirus Prevention

Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

Phase 2

Dengue Fever

TAK-341

Phase 2

Multiple System Atrophy

Drug Name	Phase	Indication	Designations
VONVENDI	Phase 3	Von Willebrand Disease (VWD)	-
REPLAGAL	Phase 3	Fabry Disease	-
IGSC 20% infusion	Phase 3	Primary Immunodeficiency Disease	-
Apremilast	Phase 3	Plaque Psoriasis	-
Febuxostat	Phase 3	Cardiovascular Disease	-
TAK-438	Phase 3	Erosive Esophagitis	-
Alogliptin and glimepiride	Phase 3	Type 2 Diabetes Mellitus	-
Pioglitazone	Phase 3	Diabetes Mellitus	-
Vedolizumab 300 mg IV	Phase 3	Colitis, Ulcerative	-
Vedolizumab SC 108 mg	Phase 3	Crohn's Disease	-
Vonoprazan	Phase 3	Helicobacter Pylori	-
Ixazomib	Phase 3	Relapsed Multiple Myeloma	-
Alogliptin and glyburide	Phase 3	Diabetes Mellitus	-
Alogliptin	Phase 3	Diabetes Mellitus	-
Azilsartan medoxomil	Phase 3	Hypertension	-
SYR-322-MET	Phase 3	Clinical Pharmacology	-
TAK-438 10 mg	Phase 3	Non-erosive Gastroesophageal Reflux Disease	-
Lapaquistat acetate	Phase 3	Hypercholesterolemia	-
Vonicog Alfa	Phase 3	Von Willebrand Disease (VWD)	-
TAK-279	Phase 3	Generalized Pustular Psoriasis	-
Relugolix	Phase 3	Uterine Fibroids	-
Metformin	Phase 3	Diabetes Mellitus	-
Dexlansoprazole MR	Phase 3	Esophagitis, Reflux	-
Alogliptin and pioglitazone	Phase 3	Type 2 Diabetes Mellitus	-
Vortioxetine	Phase 3	Major Depressive Disorder	-
Maribavir	Phase 3	Cytomegalovirus (CMV)	-
Vedolizumab	Phase 3	Ulcerative Colitis	-
TAK-559	Phase 3	Diabetes Mellitus	-
Teduglutide	Phase 3	Short Bowel Syndrome	-
Pantoprazole	Phase 3	GERD	-
Azilsartan medoxomil and chlorthalidone	Phase 3	Safety	-
Lu AA21004	Phase 3	Major Depressive Disorder	-
TAK-536TCH tablet	Phase 3	Essential Hypertension	-
YF-17D	Phase 3	Dengue	-
Vortioxetine tablets	Phase 3	Major Depressive Disorder	-
Ixazomib Citrate	Phase 3	Multiple Myeloma	-
Mezagitamab	Phase 3	Kidney Disease	-
Lapaquistat acetate and simvastatin	Phase 3	Hypercholesterolemia	-
Upadacitinib	Phase 3	Crohn's Disease	-
MOVIPREP	Phase 3	Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.	-
Lapaquistat acetate and atorvastatin	Phase 3	Dyslipidemia	-
Velaglucerase Alfa	Phase 3	Gaucher Disease	-
Lapaquistat acetate and rosuvastatin	Phase 3	Hypercholesterolemia	-
High Dose Colchicine (4.8 mg total dose)	Phase 3	Gout	-
TAK-755	Phase 3	Thrombotic Thrombocytopenic Purpura (TTP)	-
TDV	Phase 3	Healthy Volunteers	-
Fazirsiran Injection	Phase 3	Alpha1-Antitrypsin Deficiency	-
Elritercept	Phase 3	Myelodysplastic Syndromes	-
TAK-019	Phase 3	Coronavirus Disease (COVID-19)	-
NE-58095 IR	Phase 3	Involutional Osteoporosis	-
Peginesatide	Phase 3	Anemia	-
TAK-330	Phase 3	Coagulation Disorder	-
TAK-875	Phase 3	Diabetes Mellitus, Type 2	-
Idursulfase-IT	Phase 3	Hunter Syndrome	-
Azacitidine	Phase 3	Myelodysplastic Syndrome	-
Glipizide	Phase 3	Diabetes Mellitus	-
Zasocitinib	Phase 3	Nonsegmental Vitiligo	-
Lansoprazole	Phase 3	Erosive Esophagitis	-
Esomeprazole	Phase 3	Healthy Volunteers	-
Glimepiride	Phase 3	Diabetic Patients	-
Alogliptin and metformin	Phase 3	Type 2 Diabetes Mellitus	-
Parathyroid Hormone (PTH)	Phase 3	Osteoporosis	-
TAP-144-SR(6M)	Phase 3	Premenopausal Breast Cancer	-
Allopurinol	Phase 3	Hyperuricosuria	-
Venticute	Phase 3	Pneumonia	-
Azilsartan medoxomil - chlorthalidone	Phase 3	Essential Hypertension	-
Lubiprostone	Phase 3	Constipation	-
Chlorthalidone	Phase 3	Hypertension	-
Adynovate	Phase 3	Hemophilia A	-
Alogliptin and voglibose	Phase 3	Type 2 Diabetes Mellitus	-
Bismuth-Containing Quadruple Therapy	Phase 3	Duodenal Ulcer	-
Azilsartan Medoxomil and amlodipine	Phase 3	Hypertension	-
Magnesium Pantoprazole	Phase 3	GERD	-
Vedolizumab SC	Phase 3	Colitis, Ulcerative	-
Rosiglitazone	Phase 3	Diabetes Mellitus	-
Bicalutamide	Phase 3	Prostate Cancer	-
TAK-861	Phase 3	Narcolepsy Type 1	-
Azilsartan	Phase 3	Pediatric Hypertension	-
9vHPV Vaccine	Phase 3	Dengue Fever	-
TVP-1012 1mg	Phase 3	Parkinson's Disease	-
Zopiclone	Phase 3	Balance	-
Insulin	Phase 3	Diabetes Mellitus	-
Ponatinib	Phase 3	Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)	-
Duloxetine	Phase 3	Generalized Anxiety Disorder	-
Atorvastatin	Phase 3	Hypercholesterolemia	-
Olmesartan medoxomil-hydrochlorothiazide	Phase 3	Essential Hypertension	-
Ramipril	Phase 3	Hypertension	-
Vedolizumab IV	Phase 3	Crohn's Disease (CD)	-
Valsartan	Phase 3	Hypertension	-
Simvastatin	Phase 3	Hypercholesterolemia	-
Amoxicillin	Phase 3	H. Pylori Infection	-
Darvadstrocel	Phase 3	Complex Perianal Fistulas in Adult Participants With Crohn's Disease	-
Febuxostat IR	Phase 3	Gout	-
TAK-672	Phase 3	Acquired Hemophilia A	-
Tetravalent Dengue Vaccine (TDV)	Phase 3	Healthy Volunteers	-
Adalimumab	Phase 3	Colitis, Ulcerative	-
Gefarnate	Phase 3	Stomach Ulcer	-
Intranasal Fentanyl Spray (INFS)	Phase 3	Break Through Pain	-
TVP-1012 0.5mg	Phase 3	Parkinson's Disease	-
Takeda's Dengue Tetravalent Vaccine (Live, Attenuated) (TDV)	Phase 3	Dengue Fever	-
Metformin hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-
omega-3-acid ethyl esters 90 (TAK-085)	Phase 3	Hypertriglyceridemia	-
TAK-881	Phase 3	Primary Immunodeficiency Diseases (PID)	-
Pioglitazone and metformin	Phase 3	Diabetes Mellitus	-
Olmesartan medoxomil and hydrochlorothiazide	Phase 3	Essential Hypertension	-
Lansoprazole microgranules suspension	Phase 3	Gastroesophageal Reflux Disease	-
Concomitant Antibiotic Therapy	Phase 3	Pouchitis	-
TAK-788	Phase 3	Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)	-
TAK-743 300 mg	Phase 3	Hereditary Angioedema	-
Cyclobenzaprine HCl	Phase 3	Neck Pain	-
TAK-625	Phase 3	Alagille Syndrome (ALGS)	-
TAK-003	Phase 3	Dengue Fever	-
TAK-816	Phase 3	Healthy Volunteers	-
Brigatinib	Phase 3	ALK-positive Advanced NSCLC	-
Cyproterone acetate	Phase 3	Adenocarcinoma, Prostate	-
Escitalopram	Phase 3	Treatment Outcome	-
TAK-816+ DPT-TAKEDA	Phase 3	Immunization	-
Lapaquistat acetate and lipid-lowering therapy	Phase 3	Type 2 Diabetes	-
Actovegin	Phase 3	Post-Stroke Cognitive Impairment (PSCI)	-
Alectinib	Phase 3	ALK+ Advanced NSCLC	-
HAV Vaccine	Phase 3	Healthy Volunteers	-
TAK-583	Phase 3	Diabetic Neuropathies	-
Leuprorelin	Phase 3	Prostatic Neoplasms	-
Dexlansoprazole	Phase 3	Gastroesophageal Reflux Disease	-
Resatorvid	Phase 3	Sepsis	-
SYR-472	Phase 3	Diabetes Mellitus	-
Ramelteon	Phase 3	Transient Insomnia	-
Soticlestat	Phase 2	15q Duplication Syndrome	-
Zasocitinib (Dose A)	Phase 2	Hidradenitis Suppurativa	-
Norwalk VLP vaccine	Phase 2	Acute Gastroenteritis	-
TAK-853	Phase 2	Ovarian Cancer	-
Lenalidomide	Phase 2	Relapsed and/or Refractory Multiple Myeloma	-
Doxorubicin	Phase 2	Hodgkin Disease	-
NoV Vaccine	Phase 2	Healthy Volunteers	-
TDV Liquid Formulation 1	Phase 2	Dengue Fever	-
Niraparib	Phase 2	Ovarian Cancer	-
Ramelteon and gabapentin	Phase 2	Sleep Initiation and Maintenance Disorders	-
TAK-981	Phase 2	Advanced or Metastatic Solid Tumors	-
Enoxaparin	Phase 2	Venous Thromboembolism	-
TAK-442	Phase 2	Acute Coronary Syndrome	-
TAK-783 and methotrexate	Phase 2	Arthritis, Rheumatoid	-
Ramelteon and doxepin	Phase 2	Sleep Initiation and Maintenance Disorders	-
Brentuximab Vedotin	Phase 2	Hodgkin Disease	-
TAK-850 0.5 mL injection	Phase 2	Influenza Infection	-
Daratumumab	Phase 2	Multiple Myeloma	-
TIMP-GLIA	Phase 2	Celiac Disease	-
vortioxetine (Lu AA21004)	Phase 2	Depressive Disorder, Major	-
Cabozantinib	Phase 2	Advanced Hepatocellular Carcinoma	-
Panitumumab + TAS-102	Phase 2	Colorectal Cancer	-
Norovirus GI.1/GII.4 Bivalent VLP Vaccine	Phase 2	Norovirus	-
TAK-360	Phase 2	Narcolepsy Type 2	-
Sitagliptin	Phase 2	Diabetes Mellitus, Type 2	-
Voglibose	Phase 2	Diabetes Mellitus, Type 2	-
Pevonedistat	Phase 2	Acute Myeloid Leukemia (AML)	-
Norovirus Bivalent Vaccine	Phase 2	Prevention From Norovirus Infection	-
TAK-935	Phase 2	Epilepsy	-
TAK-071	Phase 2	Parkinson Disease	-
Leuprorelin (GF)	Phase 2	Uterine Fibroids	-
Subcutaneous injection of TAK-850	Phase 2	Influenza Infection	-
TAK-128	Phase 2	Diabetic Neuropathies	-
Olmesartan	Phase 2	Hypertension	-
TAK-079	Phase 2	Myasthenia Gravis	-
TAK-954	Phase 2	Diabetic Gastroparesis	-
oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab	Phase 2	Colorectal Carcinoma	-
NDI-034858	Phase 2	Psoriatic Arthritis	-
TAK-062	Phase 2	Celiac Disease	-
Pioglitazone and insulin	Phase 2	Diabetes Mellitus	-
NoV GI.1/GII.4 Bivalent VLP Vaccine	Phase 2	Healthy Volunteers	-
Hepatitis A Vaccine	Phase 2	Healthy Volunteers	-
Ilaprazole	Phase 2	Esophagitis	-
TAK-007	Phase 2	Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)	-
TAK-385	Phase 2	Endometriosis	-
Namilumab	Phase 2	Plaque Psoriasis	-
Lapaquistat acetate and fenofibrate	Phase 2	Hyperlipidemias	-
TAK-850	Phase 2	Influenza	-
Norovirus Bivalent VLP Vaccine	Phase 2	Norovirus Prevention	-
Takeda's Tetravalent Dengue Vaccine Candidate (TDV)	Phase 2	Dengue Fever	-
TAK-341	Phase 2	Multiple System Atrophy	-

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals

4502.T News